| Evolution of Memory Related Activity (NCT00902499) | National Institute on Aging (NIA) | 2006-05-01 |
| Effects of LY2062430 in Subjects With Mild-to-Moderate Alzheimer's Disease and in Healthy Volunteers (NCT00329082) | Eli Lilly and Company | 2006-05-01 |
| Safety and Tolerability of Rivastigmine With Add-on Memantine in Patients With Probable Alzheimer's Disease (NCT00305903) | Novartis | 2006-03-01 |
| Activity of Masitinib (AB1010) in Mild to Moderate Alzheimer's Disease (NCT00976118) | AB Science | 2006-02-01 |
| Safety and Efficacy Study of AC-3933 in Adults With Mild to Moderate Alzheimer's Disease (NCT00359944) | Sumitomo Pharma America, Inc. | 2006-02-01 |
| Phase II Study of Intravenous Immunoglobulin (IVIg) for Alzheimer's Disease (NCT00299988) | Weill Medical College of Cornell University | 2006-02-01 |
| Anti-Oxidant Treatment of Alzheimer's Disease (NCT00117403) | National Institute on Aging (NIA) | 2006-01-01 |
| Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive Impairment (NCT00306124) | University Hospital Muenster | 2006-01-01 |
| Quetiapine for the Treatment of Insomnia in Alzheimer's Disease (NCT00232570) | University of Vermont | 2005-11-01 |
| Clinical Research Center for Dementia of South Korea (CREDOS)(or CRCD) (NCT01198093) | Samsung Medical Center | 2005-11-01 |
| Safety and Efficacy of MEM 1003 Versus Placebo in Patients With Mild to Moderate Alzheimer's Disease (NCT00257673) | Memory Pharmaceuticals | 2005-11-01 |
| Effects of LY450139 Dihydrate on Subjects With Mild to Moderate Alzheimer's Disease (NCT00244322) | Eli Lilly and Company | 2005-10-01 |
| BONSAI: Biomarkers of Nonsteroidal Anti-Inflammatories (NCT00239746) | National Institute on Aging (NIA) | 2005-10-01 |
| Positron Emission Tomography of Amyloid in Alzheimer's Disease (NCT00205621) | Amsterdam UMC, location VUmc | 2005-10-01 |
| A Dose Ranging Study To Investigate The Efficacy And Safety Of SB-742457 In Alzheimer's Disease (NCT00224497) | GlaxoSmithKline | 2005-09-01 |
| Amyloid Plaque and Tangle Imaging in Aging and Dementia (NCT00355498) | University of California, Los Angeles | 2005-09-01 |
| Double-blind, Placebo-controlled Study of Oral Dimebon in Subjects With Mild to Moderate Alzheimer's Disease (NCT00377715) | Medivation, Inc. | 2005-09-01 |
| ALADDIN Study - Phase III: Antigonadotropin-Leuprolide in Alzheimer's Disease Drug INvestigation (VP-AD-301) (NCT00231946) | Voyager Pharmaceutical Corporation | 2005-09-01 |
| A Clinical Study Evaluating the Effects of Memantine on Brain Atrophy in Patients With Alzheimer's Disease (NCT00862940) | H. Lundbeck A/S | 2005-09-01 |
| European Study of 3APS in Mild to Moderate Alzheimer's Disease Patients (NCT00217763) | Bellus Health Inc. - a GSK company | 2005-09-01 |
| Memory Imaging of Normal Aging (NCT00315575) | National Institute on Aging (NIA) | 2005-08-01 |
| Treatment of Apathy in Alzheimer's Disease With Modafinil (NCT01172145) | Brown University | 2005-07-01 |
| Study of Memantine in Assessment of Selected Measures of Volumetric Magnetic Resonance Imaging (MRI) and Cognition in Moderate AD (Alzheimer's Disease) (NCT00334906) | Forest Laboratories | 2005-07-01 |
| Posterior Cingulate Function in Persons With Risk Factors for Alzheimer's Disease (NCT00478166) | University of Wisconsin, Madison | 2005-07-01 |
| ADNI: Alzheimer's Disease Neuroimaging Initiative (NCT00106899) | Alzheimer's Disease Cooperative Study (ADCS) | 2005-07-01 |
| Nutritional Programme for Dementia Elderly Patient (NCT00479843) | Société des Produits Nestlé (SPN) | 2005-07-01 |
| Safety and Tolerability Study in Patients With Mild to Moderate Alzheimer's Disease (AD) (NCT00411580) | Novartis Pharmaceuticals | 2005-06-01 |
| MRS and DTI of White Matter in Alzheimer's Disease (NCT00172900) | National Taiwan University Hospital | 2005-06-01 |
| Enhancing Quality of Life for Nursing Home Residents (NCT00388544) | Penn State University | 2005-05-01 |
| AAB-001 in Patients With Mild to Moderate Alzheimer's Disease (NCT00112073) | JANSSEN Alzheimer Immunotherapy Research & Development, LLC | 2005-04-01 |
| Safety Study of Passive Immunization for Patients With Mild to Moderate Alzheimer's Disease (NCT00174525) | Pharmacology Research Institute | 2005-04-01 |
| TNF-Alpha Inhibition for Treatment of Alzheimer's Disease (NCT00203320) | Tobinick, Edward Lewis, M.D. | 2005-04-01 |
| Correlation Between Regional Brain Volume and Response to Donepezil Treatment in AD Patients (NCT00165750) | Eisai Korea Inc. | 2005-03-01 |
| Study Evaluating SRA-333 in Mild to Moderate Alzheimer's Disease (AD) (NCT00151333) | Wyeth is now a wholly owned subsidiary of Pfizer | 2005-02-01 |
| Alzheimer's Disease: Potential Benefit of Isoflavones (NCT00205179) | University of Wisconsin, Madison | 2005-01-01 |
| Safety Study of PPI-1019 in Subjects With Mild-Moderate Alzheimer's Disease (NCT00100334) | PRAECIS Pharmaceuticals Inc. | 2004-12-01 |
| Effects Of Rosiglitazone (Extended Release Tablets) On Cerebral Glucose Utilisation And Cognition Alzheimers Disease (NCT00334568) | GlaxoSmithKline | 2004-12-01 |
| Tricaprilin in Mild to Moderate Alzheimer's Disease (NCT00142805) | Cerecin | 2004-11-04 |
| The Efficacy of a Combination Regimen in Patients With Mild to Moderate Probable Alzheimer's Disease (NCT01921972) | Charite University, Berlin, Germany | 2004-11-01 |
| A Pilot Trial of Interferon Beta-1a in Alzheimer's Disease (NCT01075763) | Merck KGaA, Darmstadt, Germany | 2004-11-01 |
| Brain Aging Project--Kansas University (NCT00267124) | University of Kansas Medical Center | 2004-11-01 |
| AIDMA: A Psycho-educational Program Designed to Support and Train Carers of Alzheimer's Disease (AD) Patients (NCT00190372) | Assistance Publique - Hôpitaux de Paris | 2004-10-01 |
| Alzheimer's Caregiver Communication Study (NCT00182988) | National Institute on Aging (NIA) | 2004-10-01 |
| A Pilot Study of Curcumin and Ginkgo for Treating Alzheimer's Disease (NCT00164749) | Chinese University of Hong Kong | 2004-10-01 |
| Impact of a Memory Group for Older Adults Reporting Memory Difficulties (NCT01998711) | Bayside Health | 2004-10-01 |
| An Evaluation of the Safety and Efficacy of Memantine in Agitated Patients With Moderate to Severe Alzheimer's Disease (NCT00097916) | Forest Laboratories | 2004-09-01 |
| Computer-Based Training for Mild Alzheimer's Disease (NCT00319891) | Posit Science Corporation | 2004-09-01 |
| Memory Aid for Informed Consent in Alzheimer's Research (NCT00105612) | National Institute on Aging (NIA) | 2004-09-01 |
| Rasagiline 1 mg and 2 mg Added to Aricept 10 mg Daily in Patients With Mild to Moderate Alzheimer's Disease (AD) (NCT00104273) | Teva Branded Pharmaceutical Products R&D, Inc. | 2004-08-01 |
| Depression in Alzheimer's Disease-2 (NCT00086138) | Johns Hopkins University | 2004-07-01 |
| A Randomized Study to Evaluate FK962 in Subjects With Mild to Moderate Alzheimer's Disease (NCT00087724) | Astellas Pharma Inc | 2004-07-01 |
| Alzheimer's Disease Long-term Follow-up Study (ALF Study) (NCT00165724) | Eisai Korea Inc. | 2004-06-30 |
| A Randomized, Placebo-Controlled Trial to Examine the Efficacy of Oral Donepezil in Subjects With MCI (NCT00483028) | Pfizer | 2004-06-01 |
| Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease (NCT00857233) | H. Lundbeck A/S | 2004-06-01 |
| CERE-110 in Subjects With Mild to Moderate Alzheimer's Disease (NCT00087789) | Sangamo Therapeutics | 2004-06-01 |
| Effects of ONO-2506PO in Patients With Alzheimer's Disease (NCT00083421) | Ono Pharma USA Inc | 2004-06-01 |
| Brain Imaging Study Of Rosiglitazone Efficacy And Safety In Alzheimer's Disease (NCT00265148) | GlaxoSmithKline | 2004-05-18 |
| Safety and Tolerability Study of Extended Release (ER) Galantamine in Alzheimer's Disease (NCT00082602) | Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | 2004-05-01 |
| Effect of Panax Ginseng on the Cognitive Performance in Alzheimer's Disease (NCT00391833) | Seoul National University Hospital | 2004-04-01 |
| Fish Oil and Alpha Lipoic Acid in Treating Alzheimer's Disease (NCT00090402) | Oregon Health and Science University | 2004-04-01 |
| Treatment With Copper in Patients With Mild Alzheimer´s Dementia (NCT00608946) | University Hospital, Saarland | 2004-03-01 |
| Project TAP: Tailored Activities Project (NCT00259467) | Thomas Jefferson University | 2004-02-01 |
| Mirtazapine in Alzheimer-associated Weight Loss (NCT01505504) | Brugmann University Hospital | 2004-01-01 |
| Safety and Effect on Memory of PYM50028 in Mild Alzheimer's Disease (NCT00130429) | Phytopharm | 2004-01-01 |
| Efficacy and Safety of Memantine in Moderate to Severe Alzheimer's Disease (NCT00857649) | H. Lundbeck A/S | 2003-12-01 |
| Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia (NCT00095719) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2003-12-01 |
| Rivastigmine Monotherapy and Combination Therapy With Memantine in Patients With Moderately Severe Alzheimer's Disease Who Failed to Benefit From Previous Cholinesterase Inhibitor Treatment (NCT00234637) | Novartis | 2003-11-01 |
| CALM-AD (NCT00142324) | Institute of Psychiatry, London | 2003-11-01 |
| Study of the Effects of Current Drug Treatments on Levels of Certain Brain Chemicals in Alzheimer's Disease (NCT00104442) | Novartis | 2003-10-01 |
| Study of MK0677 for the Treatment of Alzheimer's Disease (0677-030)(COMPLETED) (NCT00074529) | Merck Sharp & Dohme LLC | 2003-10-01 |
| A Study of the Safety and Efficacy of Multiple Doses of ABT-089 in Subjects With Alzheimer's Disease (NCT00069849) | Abbott | 2003-07-01 |
| Curcumin in Patients With Mild to Moderate Alzheimer's Disease (NCT00099710) | John Douglas French Foundation | 2003-07-01 |
| Use of Different Treatment Care Methods in Patients With Dementia Associated With Alzheimer's Disease (NCT00283725) | Ortho-McNeil Neurologics, Inc. | 2003-06-01 |
| Safety Study of PPI-1019 in Patients With Mild-Moderate Alzheimer's Disease (NCT00100282) | PRAECIS Pharmaceuticals Inc. | 2003-05-01 |
| Biomarkers and Early Alzheimer's Disease (NCT00094952) | National Institute on Aging (NIA) | 2003-04-01 |
| Mifepristone as Adjunctive Therapy in Alzheimer's Disease (NCT00105105) | Corcept Therapeutics | 2003-04-01 |
| Early Markers of Cognitive Change and Alzheimer s Disease (NCT01867346) | National Institute on Aging (NIA) | 2003-03-19 |
| Early Markers of Alzheimer's Disease: Structural and Functional Brain Changes (NCT01867372) | National Institute on Aging (NIA) | 2003-03-10 |
| The Safety and Efficacy of Neramexane in Patients With Moderate to Severe Alzheimer's Disease (NCT00090116) | Forest Laboratories | 2003-03-01 |
| Escitalopram Treatment of Patients With Agitated Dementia (NCT00260624) | University of Rochester | 2003-02-01 |
| An Open-label Extension to Evaluate the Efficacy and Safety of the Rivastigmine Transdermal Patch in Patients With Probable Alzheimer's Disease (NCT00219232) | Novartis | 2003-02-01 |
| Safety Study of AVP-923 in the Treatment of IEED (Involuntary Emotional Expression Disorder) Also Known as Pseudobulbar Affect (Episodes of Uncontrolled Crying and/or Laughter) (NCT00056524) | Avanir Pharmaceuticals | 2003-02-01 |
| Research on Aging Project in Iceland: Second Stage (NCT01322568) | National Institute on Aging (NIA) | 2003-01-31 |
| VITAL - VITamins to Slow ALzheimer's Disease (Homocysteine Study) (NCT00056225) | National Institute on Aging (NIA) | 2003-01-01 |
| fMRI of Vulnerable Brain Regions in Persons at Risk for Alzheimer's Disease (NCT00478491) | University of Wisconsin, Madison | 2003-01-01 |
| Clinical and Genetic Study of Neurodegenerative Disorders With Cognitive Impairment (NCT00149175) | Institut National de la Santé Et de la Recherche Médicale, France | 2002-12-01 |
| Efficacy and Safety of LY451395 in Patients With Probable Alzheimer's Disease (NCT00051909) | Eli Lilly and Company | 2002-11-01 |
| To Evaluate the Safety and Effectiveness of Atorvastatin Plus a Cholinesterase Inhibitor in AD Patients. (NCT00151502) | Pfizer's Upjohn has merged with Mylan to form Viatris Inc. | 2002-11-01 |
| MIRAGE: Multi-Institutional Research in Alzheimer's Genetic Epidemiology (NCT00239759) | National Institute on Aging (NIA) | 2002-09-01 |
| Seroquel- Agitation Associated With Dementia (NCT00621647) | AstraZeneca | 2002-09-01 |
| Do HMG CoA Reductase Inhibitors Affect Abeta Levels? (NCT00303277) | Seattle Institute for Biomedical and Clinical Research | 2002-08-01 |
| A Study of the Effectiveness and Safety of Risperidone Versus Placebo in the Treatment of Patients With Hallucinations and Delusions Associated With Alzheimer's Disease (NCT00287742) | Janssen Pharmaceutical K.K. | 2002-03-01 |
| Randomized Safety, Tolerability and Pilot Efficacy of AN-1792 in Alzheimer's Disease (NCT00021723) | JANSSEN Alzheimer Immunotherapy Research & Development, LLC | 2001-09-01 |
| Care Management for Patients With Alzheimer Disease and Their Family Caregivers (NCT00246896) | Agency for Healthcare Research and Quality (AHRQ) | 2001-08-01 |
| Project ACT: Advancing Caregiving Techniques (NCT00259480) | Thomas Jefferson University | 2001-08-01 |
| Double Blind Study of Trp01 in Patients With Alzheimer's Disease (NCT00202124) | Queen's University | 2001-04-01 |
| Effects of an Anti-Inflammatory Drug in Alzheimer's Disease (NCT00013650) | National Institute of Mental Health (NIMH) | 2001-03-22 |
| CATIE-Alzheimer's Disease Trial (NCT00015548) | National Institute of Mental Health (NIMH) | 2001-03-01 |
| Specific Interventions for Agitation in Alzheimer's Disease (NCT00018291) | US Department of Veterans Affairs | 2001-01-01 |
| Efficacy and Safety of Aricept in the Treatment of Severe Alzheimer's Disease (NCT00096473) | Eisai Inc. | 2001-01-01 |